Reversal of tumor immunosuppression and induction of potent antitumor immunity via albumin-based co-delivery of paclitaxel and a PD-L1 inhibitor
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Cancer Immunotherapy and Biomarkers
Cancer Research and Treatments
Publication details
- Journal / source
- Colloids and Surfaces A Physicochemical and Engineering Aspects
- Publisher
- Elsevier BV
- Volume
- 737
- Pages
- 139767–139767
- Publication date
- 30 January 2026
- Language
- EN